Logo

REMUS PHARMACEUTICALS L Share Price

NSE: REMUS
|
Trading
₹ 761.50
+₹15.45 (2.07%)
1D
Last updated 03 Jul, 2026, 15:28 IST

REMUS PHARMACEUTICALS L Share Price Today

As of 5 Jul 2026, REMUS PHARMACEUTICALS L share price is ₹761.50. The stock opened at ₹762.90, compared to its previous close of ₹746.05. During today's trading session, REMUS PHARMACEUTICALS L share price moved in the range of ₹761.50 to ₹777.00, with an average price of ₹769.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹580.00 and a high of ₹993.95. On the performance front, REMUS PHARMACEUTICALS L share price has declined by 0.20% over the last six months and is down 60.39% on a year-on-year basis.

₹761.50
2.07% up today
₹777.00
1D LOW
1D HIGH

REMUS PHARMACEUTICALS L Returns Calculator

Open
₹762.90
High
₹777.00
Low
₹761.50
Prev. close
₹746.05
Circuit
L
H
₹613.95
₹920.85
52-week
L
H
₹580.00
₹993.95

REMUS PHARMACEUTICALS L Shareholder Returns

REMUS PHARMACEUTICALS L Share Price History

Mkt Cap Cr
1,319.19
P/E
35.58
P/B
2.70
ROE
7.59%
D/E
0.02
ROCE
10.19%
Div. Yield
0.07%
EPS(TTM)
20.96
Turnover
0.26
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
5.00
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Remus Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Remus Pharma. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Remus Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

REMUS PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹620.36₹212.94
Other Income₹4.98₹2.83
Total Revenue₹625.34₹215.77
Total Expenses₹578.00₹185.60
Profit Before Tax₹47.34₹30.17
Tax₹8.92₹5.89
Profit After Tax₹38.42₹24.28
EPS - Basic₹65.21₹42.97
EPS - Diluted₹65.21₹42.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹47.34₹30.17
Income before WC changes₹47.57₹29.62
Change in Assets-₹3.37-₹47.34
Change in Liabilities-₹29.74₹24.88
Change in WC-₹33.11-₹22.46
Cash flow from Operations₹6.99₹1.35
Cash flow from Investing-₹10.55-₹30.11
Cash flow from Financing₹6.07₹27.67
Total Cash Flow₹2.51-₹1.09
Cash (Start of the year)₹4.72₹1.01
Cash (End of the year)₹7.23₹4.72

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹211.27₹120.78
Current Assets₹221.37₹212.33
Total Assets₹432.64₹333.11
Current Liabilities₹121.53₹141.11
Net Current Asset₹99.84₹71.22
Non-Current Liabilities₹28.56₹16.79
Equity Capital₹282.55₹175.21
Total Equity & Liabilities₹432.64₹333.11

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹79.16₹63.94₹45.03₹24.72
Other Income₹2.91₹2.81₹1.58₹0.72
Total Revenue₹82.07₹66.75₹46.60₹25.44
Total Expenses₹55.43₹44.40₹35.19₹20.82
Profit Before Tax₹26.64₹22.35₹11.41₹4.61
Tax₹6.74₹5.73₹2.91₹1.18
Profit After Tax₹19.90₹16.62₹8.50₹3.43
EPS - Basic₹33.75₹29.40₹83.24₹34.34
EPS - Diluted₹33.75₹29.40₹83.24₹34.34

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹26.64₹22.35₹11.41₹4.61
Income before WC changes₹26.69₹21.59₹11.58₹4.61
Change in Assets-₹0.58-₹15.83-₹1.77₹0.12
Change in Liabilities-₹3.00₹6.80-₹1.51₹1.50
Change in WC-₹3.58-₹9.03-₹3.27₹1.62
Cash flow from Operations₹15.59₹6.31₹5.31₹5.04
Cash flow from Investing-₹12.42-₹47.24-₹15.19-₹4.55
Cash flow from Financing-₹1.42₹41.63₹11.77-₹0.17
Total Cash Flow₹1.75₹0.70₹1.89₹0.32
Cash (Start of the year)₹1.71₹1.01₹1.15₹0.83
Cash (End of the year)₹3.46₹1.71₹3.04₹1.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹226.40₹134.61₹23.32₹8.17
Current Assets₹53.91₹48.88₹11.34₹7.69
Total Assets₹280.31₹183.49₹34.66₹15.86
Current Liabilities₹11.08₹14.92₹8.16₹9.18
Net Current Asset₹42.83₹33.96₹3.18-₹1.49
Non-Current Liabilities₹27.01₹15.02₹7.36₹0.10
Equity Capital₹242.22₹153.55₹19.14₹6.58
Total Equity & Liabilities₹280.31₹183.49₹34.66₹15.86
* All values are in INR Crore
Qty
Bid
100
767.4
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 100
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
52.15
Neutral
ATR (14)
36.9
Neutral
STOCH(9,6)
59.37
Neutral
STOCH RSI (14)
24.52
Neutral
ADX(9)
23.16
Bearish
UO(9)
56.43
Neutral
ROC(12)
-0.58
Bearish
WillR(14)
-48.52
Neutral
Period
Simple value
Exponential vaue
5D
760.11
763.49
10D
777.65
766.58
20D
753.81
761.15
50D
742.1
739.38
100D
696.78
717.82

About REMUS PHARMACEUTICALS L

REMUS PHARMACEUTICALS L logo
ISIN
INE0O5T01011
Sector Market Cap
₹ 1,319.19 Cr

Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.

REMUS PHARMACEUTICALS L Financial Highlights

  • Revenue: REMUS PHARMACEUTICALS L reported revenue of ₹860.33 crore in FY26 vs ₹625.34 crore in FY25. It showed an increase of 37.58% on a yearly basis.
  • Operating Profit: REMUS PHARMACEUTICALS L reported an operating profit of ₹59.16 crore in FY26 vs ₹47.34 crore in FY25. It showed an increase of 24.97% on a year-on-year basis.
  • Net Profit: REMUS PHARMACEUTICALS L reported a net profit of ₹46.17 crore in FY26 vs ₹38.42 crore in FY25. It showed an increase of 20.17% on a yearly basis.
Know more
Promoters
70.95%
FII
5.28%
Other DII
0.83%
Retail and other
22.93%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
REMUS PHARMACEUTICALS L logo
REMUS PHARMACEUTICALS L
Trading
Add Stock
Add Another

FAQs on REMUS PHARMACEUTICALS L Share Price